Connect with us
Tryp Therapeutics is seeking approval from U.S. regulators for a clinical trial on psilocybin-assisted therapy to help those with irritable bowel syndrome (IBS). Tryp Therapeutics announced on Wednesday...
New York-based biopharmaceutical developer MindMed announced last week that it has dosed the first patient in a clinical trial of LSD as a treatment for generalized...
